International Journal of Clinical Oncology

, Volume 3, Issue 6, pp 396–399 | Cite as

Recurrent angiosarcoma effectively treated with superselective continuous intra-arterial injection of recombinant interleukin-2 combined with radiotherapy

  • M. Wakisaka
  • N. Fuwa
  • Y. Ito
  • K. Koyama
  • E. Kato
  • K. Morita
Case Report

Abstract

We report a case of recurrent angiosarcoma (AS) in a 63-year-old man, effectively treated with a superselective continuous intra-arterial injection of recombinant interleukin-2 (rIL-2) combined with electron beam radiotherapy. The patient, who had undergone surgical resection for AS on his face near the nasal bridge, was admitted to our hospital because of recurrent AS on his bilateral cheeks. We placed 4-French catheters in the right external carotid artery (ECA) and superselectively in the left facial artery. A continuous intra-arterial injection of rIL-2 was administered in combination with radiotherapy using a 6 MeV electron beam. The lesion rapidly decreased in size. The total dose of rIL-2 was 3.72 × 107 IU (International Unit) in the right ECA and 2.96 × 107 IU in the left facial artery, while the total radiation dose was 50 Gy, in 25 fractions, for the tumor on the right cheek and 46 Gy, in 23 fractions, for the erythematous plaque on the left cheek. The patient was discharged with almost no cutaneous lesion on his cheeks. Unfortunately, there was another recurrence of AS and the patient died of respiratory failure due to lung metastases. However, as the lesion could be completely controlled even for a while, we believe this treatment method will contribute to the future management of AS.

Key words

Angiosarcoma Interleukin-2 Intra-arterial injection Radiotherapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holden CA, Spittle MF, Wilson Jones E (1987) Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 59:1046–1057Google Scholar
  2. 2.
    Masuzawa M, Higashi K, Nishioka K, Nishiyama S (1988) Successful immunotherapy for malignant hemangioendothelioma using recombinant interleukin-2. Jpn J Dermatol 98:367–369Google Scholar
  3. 3.
    Masuzawa M, Ohkawa T, Inamura K, et al. (1989) Effects of intralesional injective recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma. Jpn J Dermatol 99:1459–1466Google Scholar
  4. 4.
    Fujioka A, Sezai Y (1991) A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2. Jpn J Dermatol 101:959–963Google Scholar
  5. 5.
    Takano M, Suzuki Y, Asai T, et al. (1991) A dramatic effect of continuous intra-arterial injective recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma. Jpn J Dermatol 101:719–725Google Scholar
  6. 6.
    Murakami M, Kuroda Y, Sano A, et al. (1992) A malignant hemangioendothelioma of the scalp treated by radiation and rIL-2. Jpn J Cancer Clin 38:51–57Google Scholar
  7. 7.
    Furue M, Yamada N, Takahashi T, et al. (1994) Immunotherapy for Stewart-Treves syndrome: Usefulness of intrapleural administration of tumor-infiltrating lymphocytes against massive pleural effusion caused by metastatic angiosarcoma. J Am Acad Dermatol 30:899–903Google Scholar
  8. 8.
    Tada S, Kuroki Y, Sakaguchi E, et al. (1991) Treatment of angiosarcoma in the head of aged patients - effectiveness of extensive massive electron beam therapy. Jpn J Dermatol 101:1303–1322Google Scholar
  9. 9.
    Rosai J (1996) Ackerman's surgical pathology. 8th edn. CV Mosby, St. LouisGoogle Scholar
  10. 10.
    Damle NK, Doyle LV, Bender JR, Bradley EC (1987) Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol 138:1779–1785Google Scholar
  11. 11.
    Fuwa N, Ito Y, Koyama K, et al. (1996) A combination therapy of continuous superselective intraarterial CBDCA infusion and radiation for locally advanced head and neck cancer: Phase 1 study. Head and Neck Cancer 22:139–143Google Scholar
  12. 12.
    Ito Y, Fuwa N, Muramoto H, et al. (1995) Continuous intra-arterial infusion therapy via the occipital artery for head and neck tumors: Second choice treatment. Nippon Acta Radiol 55:1066–1067Google Scholar
  13. 13.
    Masuzawa M (1991) Effective rIL-21ocal-administration for malignant hemangioendothelioma. Biotherapy 5:1774–1780Google Scholar
  14. 14.
    Rosai J, Sumner HW, Major MC, et al. (1976) Angiosarcoma of the skin: A clinicopathologic and fine structural study. Hum Pathol 7:83–109Google Scholar
  15. 15.
    Mizutani Y, Uchida A, Fujimoto T, et al. (1989) Enhancement by X-ray irradiation of target cell susceptibility to natural killer cells. Immunol Lett 22:247–252Google Scholar

Copyright information

© The Japan Society of Clinical Oncology 1998

Authors and Affiliations

  • M. Wakisaka
    • 1
  • N. Fuwa
    • 2
  • Y. Ito
    • 2
  • K. Koyama
    • 2
    • 3
  • E. Kato
    • 2
  • K. Morita
    • 2
  1. 1.Department of RadiologyOita Medical UniversityOitaJapan
  2. 2.Department of Radiation OncologyAichi Cancer Center HospitalNagoyaJapan
  3. 3.Department of RadiologyAichi Prefectural HospitalOkazakiJapan

Personalised recommendations